Cancer Immunotherapy and Immunomodulation

Author(s): Guangdi Wang .

Journal Name: Current Medicinal Chemistry

Volume 26 , Issue 17 , 2019

[1]
Zhao, L.M.; Zhang, J.H., Histone deacetylase inhibitors in tumor immunotherapy. Curr. Med. Chem., 2019, 26, (17), 2990-3008.
[2]
Li, B.; Chan, H.L.; Chen, P., Immune checkpoint inhibitors: basics and challenges. Curr. Med. Chem., 2019, 26, (17), 3009-3025.
[3]
Zhou, W.; Guo, S.; Liu, M.; Burow, M.E.; Wang, G., Targeting CXCL12/CXCR4 axis in tumor immunotherapy. Curr. Med. Chem., 2019, 26, (17), 3026-3041.
[4]
Patanaponpibul, M.; Chen, Q.H., Immune modulation of Asian folk herbal medicines and related chemical components for cancer management. Curr. Med. Chem., 2019, 26, (17), 3042-3067.
[5]
Hao, L.; Li, T.; Chang, L.J.; Chen, X., Adoptive immunotherapy for B-cell malignancies using CD19-targeted chimeric antigen receptor T-cells: A systematic review of efficacy and safety. Curr. Med. Chem, 2019, 26, (17), 3068-3079.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 26
ISSUE: 17
Year: 2019
Page: [2988 - 2989]
Pages: 2
DOI: 10.2174/092986732617190820123515

Article Metrics

PDF: 12
HTML: 2